Compare MPLX LP (MPLX) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MPLX LP vs Smith & Nephew plc — how do they compare? MPLX LP trades at $56.75 (market cap $57.97B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: MPLX LP is far larger — about 4.6× Smith & Nephew plc's market cap, and MPLX LP pays the higher dividend (7.54%). Which is the better fit depends on your goals.
| MPLX | SNN | |
|---|---|---|
Market Cap | $57.97B | $12.64B |
Sector | Technology | Health |
52-Week High | $59.17 | $38.70 |
52-Week Low | $47.80 | $28.73 |
Enterprise Value | $82.60B | $15.41B |
Dividend Yield | 7.54% | 2.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
